cromakalim has been researched along with baclofen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baeyens, JM; Barrios, M; Del Pozo, E; Ocaña, M | 1 |
| Baeyens, JM; Barrios, M; Ocaña, M | 1 |
| Hosseinzadeh, H; Stone, TW | 1 |
3 other study(ies) available for cromakalim and baclofen
| Article | Year |
|---|---|
Subgroups among mu-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Animals; Baclofen; Benzopyrans; Cromakalim; Female; Mice; Neurons; Pain; Potassium Channels; Pyrroles; Receptors, Opioid, mu; Sulfonylurea Compounds; Tetraethylammonium; Tetraethylammonium Compounds | 1995 |
Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
Topics: Animals; Baclofen; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred Strains; Morphine; Nociceptors; Pain; Pyrroles; Receptors, Opioid, kappa; Receptors, Opioid, mu; Vasodilator Agents | 1996 |
Tolbutamide blocks postsynaptic but not presynaptic effects of adenosine on hippocampal CA1 neurones.
Topics: Adenosine; Animals; Baclofen; Calcium; Cardiovascular Agents; Cromakalim; Electric Stimulation; GABA Agonists; Hippocampus; Hypoglycemic Agents; Male; Neurons; Potassium Channel Blockers; Potassium Channels; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Presynaptic; Synapses; Tolbutamide | 1998 |